Publication | Closed Access

Identification of 2,4-dihydroxy-5-pyrimidinyl imidothiocarbomate as a novel inhibitor to Y box binding protein-1 (YB-1) and its therapeutic actions against breast cancer

Medicinal ChemistryBreast OncologyBiochemistryTherapeutic ActionsMedicineNatural SciencesBreast CancerY BoxAnti-cancer AgentPharmacologyDrug Discovery